Global Transdermal Preparation Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Transdermal Preparation Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
A transdermal preparation, which may also be considered a Transdermal Drug Delivery System (TDDS), is defined as a flexible, multi-layered, pharmaceutical single dose preparation of varying size containing one or more active substances to be applied to the intact skin for systemic absorption.
Transdermal Preparation report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Transdermal Preparation market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Transdermal Preparation industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Transdermal Preparation key manufacturers include Viatris, ERCO Pharma, MEDRx, Novartis, GSK, 4P Therapeutics, Transdermal Corporation, Medpharm and Nitto, etc. Viatris, ERCO Pharma, MEDRx are top 3 players and held % sales share in total in 2022.
Transdermal Preparation can be divided into Injectable Preparations and Non Injectable Preparations, etc. Injectable Preparations is the mainstream product in the market, accounting for % sales share globally in 2022.
Transdermal Preparation is widely used in various fields, such as Hospital, Clinic and Other,, etc. Hospital provides greatest supports to the Transdermal Preparation industry development. In 2022, global % sales of Transdermal Preparation went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transdermal Preparation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Viatris
ERCO Pharma
MEDRx
Novartis
GSK
4P Therapeutics
Transdermal Corporation
Medpharm
Nitto
Hunan Jiudian Pharmaceutical
Beijing Tide Pharmaceutical
Luye Pharma Group
Guangzhou Continent Biomedical Technology
Harbin Hexinotai Pharmaceutical Technology
Demo Technology
Novastage Pharmaceuticals (Shenzhen)
Segment by Type
Injectable Preparations
Non Injectable Preparations
Hospital
Clinic
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Transdermal Preparation market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Transdermal Preparation, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Transdermal Preparation industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Transdermal Preparation in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Transdermal Preparation introduction, etc. Transdermal Preparation Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Transdermal Preparation market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Transdermal Preparation report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Transdermal Preparation market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Transdermal Preparation industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Transdermal Preparation key manufacturers include Viatris, ERCO Pharma, MEDRx, Novartis, GSK, 4P Therapeutics, Transdermal Corporation, Medpharm and Nitto, etc. Viatris, ERCO Pharma, MEDRx are top 3 players and held % sales share in total in 2022.
Transdermal Preparation can be divided into Injectable Preparations and Non Injectable Preparations, etc. Injectable Preparations is the mainstream product in the market, accounting for % sales share globally in 2022.
Transdermal Preparation is widely used in various fields, such as Hospital, Clinic and Other,, etc. Hospital provides greatest supports to the Transdermal Preparation industry development. In 2022, global % sales of Transdermal Preparation went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transdermal Preparation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Viatris
ERCO Pharma
MEDRx
Novartis
GSK
4P Therapeutics
Transdermal Corporation
Medpharm
Nitto
Hunan Jiudian Pharmaceutical
Beijing Tide Pharmaceutical
Luye Pharma Group
Guangzhou Continent Biomedical Technology
Harbin Hexinotai Pharmaceutical Technology
Demo Technology
Novastage Pharmaceuticals (Shenzhen)
Segment by Type
Injectable Preparations
Non Injectable Preparations
Segment by Application
Hospital
Clinic
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Transdermal Preparation market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Transdermal Preparation, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Transdermal Preparation industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Transdermal Preparation in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Transdermal Preparation introduction, etc. Transdermal Preparation Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Transdermal Preparation market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices